PharmTech News

Feliza Mirasol is the science editor for 

Articles

The 2024 CPHI Pharma Awards comprise finalists spanning 14 categories and includes awards for future leaders, women of the year, and an “at the heart of pharma” category.

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

CDER’s Jonathan Chapman, senior policy advisor, and Takeda’s Paulien Groll, head of Compliance Excellence, discussed how companies can be proactive with their CAPA strategies instead of reactive, at the 2024 PDA/FDA Joint Regulatory Conference.

PDA/FDA Joint Regulatory Conference: Proactive CAPA

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

This Behind the Headlines news roundup panel discussion covers news items such as the weight loss drugs battle between Novo Nordisk and Eli Lilly, entering new territory through Lilly’s partnership with HAYA Therapeutics and long non-coding sequence mining. There was much discussion on how the inflation reduction act and Medicare price controls may or may not pertain—given the uncertainty around the presidential election results, and subsequent policy directions. The Centers for Disease Control making cost free COVID-19 diagnostics and therapies available was also evaluated. 

Behind the Headlines: Weight Loss Drugs; Price Controls; and Free COVID Therapies

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Among the design features of the machine is software-based tracking that is meant to ensure that products that are temperature-sensitive do not exceed their time limit in the solution.

Steriline to Show New Robotic Vial Filling and Capping Machine at CPHI Milan 2024

Mike Hennessy Jr. is the President and CEO of 

A coordinated and international response is needed to help control the latest mpox outbreak in Africa.

Responding to Mpox

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Bio/pharma companies should be approaching their decarbonization journey as a strategic business move for the future as industry stakeholders are placing greater value on sustainability.

Strategic Decarbonization

This is the company’s largest single investment in the Sweden Biomanufacturing Center, in Södertälje, which opened in 2021.

AstraZeneca Makes Additional $135 Million Investment in Swedish Biologics Facility

Opaganib was given orphan drug designation for the treatment of neuroblastoma in children, which is rare, but the most common infancy malignancy.

FDA Grants Orphan Drug Designation to RedHill’s Treatment for Neuroblastoma

The collaboration builds on Novartis’ acquisition of Chinook Therapeutics just over a year ago.

Novartis, Versant Create Borealis Biosciences to Develop Kidney Disease Treatments

The approvals and authorizations come amid a late summer surge in the virus that is tracking a bit earlier than the early fall wave in the US in 2023.

Industry News